← Medical · All 20 for COVID-19 (residual / endemic)
COVID-19 (residual / endemic) · Infectious
High ambulatory volume; global budgets constrain growth. Vaccination + antivirals for high-risk; hospital surge plans residual. Infectious pathway via NHI single payer.
NHI single payer
NHI single payer with smart-card claims; low waiting
Same broad infectious toolkit as peers — differences are coverage rules, wait times, prices, and follow-through.